On September 28, 2021, Triall introduced its platform-native utility token TRL. The launch of TRL followed a successful crowdfunding campaign that built a community of over 1,500 investors across the globe.
TRL is a key building block of the envisioned Triall data ecosystem, where it will coordinate fair and equitable exchange of clinical data resources between data providers, data consumers, and service providers.
TRL brings together a multi-disciplinary community of 2,300 TRL holders and 7,000+ members from 50+ countries.
TRL coordinates access to Triall software and services.
For patient and investigator communities, promoting trial recruitment, retention, and engagement.
Enabling fractional data ownership between Sponsor, CROs, Sites, and patients.
TRL enables to coordinate milestone-based payments and reimbursements through programmable contracts and workflows.
The TRL community brings together people from different backgrounds, cultures, and geographies who share a common interest in promoting Triall’s vision for clinical research. Their support as investors and advocates has been and continues to be a key success driver of the Triall ecosystem.